NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Genomic Expression, Inc.

Genomic Expression, Inc.

Private
Beverly, MassachusettsHealthcare & Life Scienceshttps://www.genomicexpression.com/

Last Round

Seed

Nov 15, 2024

Total Funding Raised

$8.42M

Company Overview

Genomic Expression, Inc. is a biotechnology company that provides RNA-based diagnostic services and develops AI-driven platforms for personalized cancer treatment and drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials, Healthcare Analytics

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting, Government Contracts

AI Layer

Application

Keywords

RNA sequencingcancer diagnosticsprecision medicinecompanion diagnosticsoncologypersonalized medicinebiomarker discoverygenomic testingNGSclinical decision supportdrug discoverynext-gen sequencingmRNA analysisCLIA laboratorytranscriptomicsliquid biopsy

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Genomic Expression, Inc. Comparables

Compare Genomic Expression, Inc. with similar companies based on industry and business-model similarity.

Genomic Expression, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Cofactor Genomics
84%
BostonGene
76%
Strata Oncology
76%

Genomic Expression, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedNov 15, 2024
CrowdfundingNov 1, 2023
Convertible DebtNov 1, 2021
SeedMay 1, 2015

Key People

Founding team and executive leadership

Gitte Pedersen

CEO and Founder

Founding Team

Genomic Expression, Inc. Investors

Notable investors and investment history

Genomic Expression, Inc. investors
InvestorRounds
National Cancer InstituteGrant
Innovation Fund DenmarkGrant
Pipeline AngelsSeed
Eurostars SME programmeGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 1, 2021

    $90K raised in convertible debt financing.

Genomic Expression, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Genomic Expression, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Genomic Expression, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersBeverly, Massachusetts
Employee Range12
Year Founded2009
Last FundingNov 15, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.